02/10/2020
7:15 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2020
3:12 PM | Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
3:11 PM | TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2020
3:10 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:10 PM | TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:09 PM | Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:08 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
3:01 PM | Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
01/13/2020
7:20 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
7:01 AM | TRACON Pharmaceuticals (Filer)
| Form 424B5
| |
12/20/2019
6:14 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2019
9:47 AM | Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2019
3:52 PM | TRACON Pharmaceuticals (Filer)
| Form 424B3
| |
11/25/2019
3:18 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2019
11:15 PM | TRACON Pharmaceuticals (Filer)
| Form EFFECT
| |
11/12/2019
3:43 PM | TRACON Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/06/2019
4:08 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2019
3:18 PM | TRACON Pharmaceuticals (Filer)
| Form DEF 14A
| |
10/21/2019
7:20 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2019
4:02 PM | TRACON Pharmaceuticals (Filer)
| Form PRE 14A
| |
10/08/2019
11:15 PM | TRACON Pharmaceuticals (Filer)
| Form EFFECT
| |
10/03/2019
3:34 PM | TRACON Pharmaceuticals (Filer)
| Form S-3/A
| |
09/30/2019
5:24 PM | Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/20/2019
3:12 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2019
3:20 PM | TRACON Pharmaceuticals (Filer)
| Form CT ORDER
| |
09/11/2019
3:16 PM | TRACON Pharmaceuticals (Filer)
| Form CT ORDER
| |
09/06/2019
3:18 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2019
3:36 PM | TRACON Pharmaceuticals (Filer)
| Form S-3/A
| |
08/16/2019
4:01 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2019
10:40 AM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2019
4:11 PM | TRACON Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2019
3:11 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2019
1:20 PM | TRACON Pharmaceuticals (Issuer)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
11:36 AM | LARUE WILLIAM R (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
11:34 AM | MATTINGLY MARTIN A (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
11:32 AM | TRACON Pharmaceuticals (Issuer)
Twiford J Rainer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
11:31 AM | TRACON Pharmaceuticals (Issuer)
WORLAND STEPHEN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:10 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2019
4:16 PM | TRACON Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2019
3:14 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2019
8:30 PM | LYTTON LAURENCE W (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
04/25/2019
3:05 PM | TRACON Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/15/2019
1:48 PM | TRACON Pharmaceuticals (Filer)
| Form CT ORDER
| |
04/12/2019
6:04 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2019
6:09 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2019
8:24 PM | TRACON Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/14/2019
10:45 AM | 683 Capital Management, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/13/2019
3:38 PM | Nextech III Oncology, LPCI (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/13/2019
11:43 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
01/29/2019
12:56 PM | Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
01/23/2019
3:48 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
3:05 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2018
5:32 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2018
4:00 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2018
9:14 AM | Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
| Form 4/A
| |
12/03/2018
8:39 AM | Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
Puissance Life Science Opportunities Fund VI (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2018
4:15 PM | TRACON Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/06/2018
8:29 PM | TRACON Pharmaceuticals (Filer)
| Form 424B5
| |
09/06/2018
8:19 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2018
4:08 PM | TRACON Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2018
3:09 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2018
3:53 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2018
7:05 PM | TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2018
7:04 PM | MATTINGLY MARTIN A (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2018
7:04 PM | TRACON Pharmaceuticals (Issuer)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2018
7:03 PM | LARUE WILLIAM R (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2018
7:02 PM | TRACON Pharmaceuticals (Issuer)
Twiford J Rainer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2018
7:01 PM | TRACON Pharmaceuticals (Issuer)
WORLAND STEPHEN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2018
3:22 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2018
7:04 PM | TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2018
6:59 PM | TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/21/2018
11:15 PM | TRACON Pharmaceuticals (Filer)
| Form EFFECT
| |
05/21/2018
4:25 PM | TRACON Pharmaceuticals (Filer)
| Form 424B3
| |
05/09/2018
3:16 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2018
3:58 PM | TRACON Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/25/2018
3:51 PM | TRACON Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/23/2018
7:00 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2018
4:25 PM | Puissance Cross-Border Opportunities V LLC (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13D/A
| |
04/10/2018
3:15 PM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2018
3:07 PM | TRACON Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/09/2018
7:53 PM | TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2018
3:44 PM | Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2018
11:45 AM | Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G
| |
03/27/2018
3:54 PM | NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
Viswanathan Ravi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:53 PM | NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
Sonsini Peter W. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:53 PM | NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:52 PM | MOTT DAVID M (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:52 PM | KERINS PATRICK J (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:51 PM | Florence Anthony A. Jr. (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:51 PM | BASKETT FOREST (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:51 PM | BARRIS PETER J (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:50 PM | BARRETT M JAMES (Reporting)
NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
3:49 PM | NEA 14 GP, LTD (Reporting)
NEA Partners 14, L.P. (Reporting)
New Enterprise Associates 14, L.P. (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2018
7:40 AM | TRACON Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2018
8:59 PM | TRACON Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/23/2018
6:02 PM | BITAR PATRICIA L (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2018
6:01 PM | THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2018
10:42 AM | 683 Capital Management, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/14/2018
8:53 AM | LYTTON LAURENCE W (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/13/2018
7:21 AM | JAFCO Super V3 Investment Limited Partnership (Filed by)
TRACON Pharmaceuticals (Subject)
| Form SC 13G/A
| |
